Development of a Nomogram to Predict the Risk for Acute Necrotizing Pancreatitis

다국어 초록 (Multilingual Abstract)

Background/Aims: Necrotizing pancreatitis (NP) presents a more severe clinical trajectory and increased mortality compared to edematous pancreatitis. Prompt identification of NP is vital for patient prognosis. A risk prediction model for NP among Chinese patients has been developed and validated to aid in early detection.
Methods: A retrospective analysis was performed on 218 patients with acute pancreatitis (AP) to examine the association of various clinical variables with NP. The least absolute shrinkage and selection operator (LASSO) regression was utilized to refine variables and select predictors.
Subsequently, a multivariate logistic regression was employed to construct a predictive nomogram.
The model's accuracy was validated using bootstrap resampling (n=500) and its calibration assessed via a calibration curve. The model's clinical utility was evaluated through decision curve analysis.
Results: Of the 28 potential predictors analyzed in 218 AP patients, the incidence of NP was 25.2%. LASSO regression identified 14 variables, with procalcitonin, triglyceride, white blood cell count at 48 hours post-admission, calcium at 48 hours post-admission, and hematocrit at 48 hours post-admission emerging as independent risk factors for NP. The resulting nomogram accurately predicted NP risk with an area under the curve of 0.822, sensitivity of 82.8%, and specificity of 76.4%. The bootstrap-validated area under the curve remained at 0.822 (95% confidence interval, 0.737 to 0.892). This model exhibited excellent calibration and demonstrated greater predictive efficacy and clinical utility for NP than APACHE II, Ranson, and BISAP.
Conclusions: We have developed a prediction nomogram of NP that is of great value in guiding clinical decision.

참고문헌 (Reference)

• 1 Moons KG, "Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis(TRIPOD) : explanation and elaboration" 162 : W1-W73, 2015
• 2 Hidalgo NJ, "The role of high serum triglyceride levels on pancreatic necrosis development and related complications" 23 : 51-, 2023
• 3 Asim Riaz HM, "The evaluation of inflammatory biomarkers in predicting progression of acute pancreatitis to pancreatic necrosis : a diagnostic test accuracy review" 11 : 27-, 2022
• 4 Ugurlu ET, "The effect of procalcitonin and immature granulocyte ratio in predicting the development of acute necrotizing pancreatitis : evidence from 582 cases" 26 : 7514-7521, 2022
• 5 Di Martino M, "Systematic review and meta-analysis of fluid therapy protocols in acute pancreatitis : type, rate and route" 23 : 1629-1638, 2021
• 6 Ünal Y, "Role of increased immature granulocyte percentage in the early prediction of acute necrotizing pancreatitis" 25 : 177-182, 2019
• 7 Xue E, "Preexisting diabetes, serum calcium and D-dimer levels as predictable risk factors for pancreatic necrosis of patients with acute pancreatitis : a retrospective study" 16 : 913-921, 2022
• 8 Leonard-Murali S, "Necrotizing pancreatitis : a review for the acute care surgeon" 221 : 927-934, 2021
• 9 Silva-Vaz P, "Multifactorial scores and biomarkers of prognosis of acute pancreatitis : applications to research and practice" 21 : 338-, 2020
• 10 Yu S, "Low serum ionized calcium, elevated high-sensitivity C-reactive protein, neutrophil-lymphocyte ratio, and body mass index(BMI)are risk factors for severe acute pancreatitis in patients with hypertriglyceridemia pancreatitis" 25 : 6097-6103, 2019
• 11 Mosztbacher D, "Hypertriglyceridemia-induced acute pancreatitis : a prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases" 20 : 608-616, 2020
• 12 Yang AL, "Hypertriglyceridemia and acute pancreatitis" 20 : 795-800, 2020
• 13 Dong X, "Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity" 21 : 49-, 2022
• 14 Acehan F, "Factors predicting the development of necrosis in patients presenting with edematous acute pancreatitis" 51 : 1300-1307, 2022
• 15 Hagjer S, "Evaluation of the BISAP scoring system in prognostication of acute pancreatitis : a prospective observational study" 54 : 76-81, 2018
• 16 Jha AK, "Endotherapy for pancreatic necrosis : an update" 3 : 80-88, 2019
• 17 Kiss S, "Early prediction of acute necrotizing pancreatitis by artificial intelligence : a prospective cohort-analysis of 2387 cases" 12 : 7827-, 2022
• 18 Warndorf MG, "Early fluid resuscitation reduces morbidity among patients with acute pancreatitis" 9 : 705-709, 2011
• 19 Wu BU, "Early changes in blood urea nitrogen predict mortality in acute pancreatitis" 137 : 129-135, 2009
• 20 Khanna AK, "Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis" 2013 : 367581-, 2013
• 21 Cheng L, "Clinical significance of serum triglyceride elevation at early stage of acute biliary pancreatitis" 15 : 19-, 2015
• 22 Yu L, "Clinical characteristics and risk factors of organ failure and death in necrotizing pancreatitis" 23 : 19-, 2023
• 23 Banks PA, "Classification of acute pancreatitis : 2012. Revision of the Atlanta classification and definitions by international consensus" 62 : 102-111, 2013
• 24 Garg PK, "Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis" 3 : 159-166, 2005
• 25 Koutroumpakis E, "Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis : a post hoc analysis of three large prospective databases" 110 : 1707-1716, 2015
• 26 Colvin SD, "Acute pancreatitis : an update on the revised Atlanta classification" 45 : 1222-1231, 2020
• 27 Leppäniemi A, "2019 WSES guidelines for the management of severe acute pancreatitis" 14 : 27-, 2019